|
Market Cap (5-Jun) $4,172,944 (725th) |
Close (30-Jun) $0.260 |
Volume (30-Jun) 239,872 |
Shortsold (5-Oct) 64,772 (0.03%) (542nd) |
|
52w High $0.043 |
52w Low $0.012 |
P/E 11.29 |
EPS -0.06 |
UBI released this announcement to the ASX on 2 March 2022, 8:28. The announcement is marked as price sensitive, and is 33 page(s) in length and 0.91MB in size.
You can view all announcements from UBI and see how they appear on a price chart on the announcements page.
At the date of this announcement, UBI was 0.008% short sold according to ASIC data. It was ranked the 639th most shorted stock on the ASX. It is now ranked as the 542nd most shorted stock on the ASX with 0.030% of total shares short sold as of the latest reported data (05 October 2023).
| Other Recent Announcements from UBI | |
|---|---|
| Results of 2023 Annual General meeting | 22 May 2023, 12:14 |
| CEO's AGM address to Securityholders | 22 May 2023, 8:33 |
| Q1 2023 Results | 11 May 2023, 15:41 |
| UBI Investor Presentation | 2 March 2022, 8:28 |
| Regulatory Approval to sell Xprecia Prime in Europe | 28 February 2022, 9:17 |
| Application for quotation of securities - UBI | 25 February 2022, 16:57 |
| Appendix 4E and Annual Report on Form 10-K FY2021 | 24 February 2022, 15:50 |
You must be logged in to post a reply.
Universal Biosensors, Inc 